Aurinia Pharmaceuticals Inc. | Small-cap | Healthcare
$7.47
-1.58%
| Aurinia Stock Comparison:
Aurinia vs VertexAurinia vs RegeneronAurinia vs Vera TherapeuticsAurinia vs Immunocore HoldingsAurinia vs AgiosAurinia vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 235.1M
Gross Profit 206.9M 87.99%
Operating Income 18.4M 7.83%
Net Income 5.8M 2.45%
EPS (Diluted) $0.04

Balance Sheet Metrics

Total Assets 550.6M
Total Liabilities 173.2M
Shareholders Equity 377.5M
Debt to Equity 0.46

Cash Flow Metrics

Operating Cash Flow 51.5M
Free Cash Flow 44.1M

Revenue & Profitability Trend

Aurinia Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue235.1M175.5M134.0M45.6M50.1M
Cost of Goods Sold28.2M14.1M5.7M1.1M0
Gross Profit206.9M161.4M128.4M44.5M50.1M
Operating Expenses188.5M253.1M239.8M225.2M154.4M
Operating Income18.4M-91.7M-111.5M-180.7M-104.3M
Pre-tax Income7.4M-77.5M-106.4M-180.2M-102.8M
Income Tax1.7M551.0K1.8M760.0K-94.0K
Net Income5.8M-78.0M-108.2M-181.0M-102.7M
EPS (Diluted)$0.04-$0.54-$0.76-$1.40-$0.87

Income Statement Trend

Aurinia Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets446.6M424.8M442.5M513.3M419.4M
Non-Current Assets104.0M123.3M28.3M30.0M44.2M
Total Assets550.6M548.1M470.9M543.4M463.7M
Liabilities
Current Liabilities97.8M77.2M46.1M40.6M32.0M
Non-Current Liabilities75.4M92.9M19.3M23.6M23.9M
Total Liabilities173.2M170.1M65.4M64.3M55.9M
Equity
Total Shareholders Equity377.5M378.0M405.4M479.1M407.8M

Balance Sheet Composition

Aurinia Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income5.8M-78.0M-108.2M-181.0M-102.7M
Operating Cash Flow51.5M-32.6M-79.2M-153.3M-91.5M
Investing Activities
Capital Expenditures-281.0K-718.0K-292.0K-303.0K-5.7M
Investing Cash Flow39.3M-6.7M-60.6M-102.7M-156.5M
Financing Activities
Dividends Paid-----
Financing Cash Flow-58.4M-10.0M0196.7M187.7M
Free Cash Flow44.1M-34.2M-79.8M-159.2M-77.2M

Cash Flow Trend

Aurinia Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 29.00
Forward P/E 14.50
Price to Book 3.08
Price to Sales 4.28
PEG Ratio 14.50

Profitability Ratios

Profit Margin 16.11%
Operating Margin 37.43%
Return on Equity 11.23%
Return on Assets 5.20%

Financial Health

Current Ratio 5.93
Debt to Equity 22.25
Beta 1.16

Per Share Data

EPS (TTM) $0.27
Book Value per Share $2.54
Revenue per Share $1.74

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
auph1.1B29.003.0811.23%16.11%22.25
Vertex 114.1B32.826.92-5.64%-8.91%10.00
Regeneron 55.3B13.021.8415.96%31.94%9.20
Vera Therapeutics 1.4B-8.412.58-39.49%0.00%10.18
Immunocore Holdings 1.6B-31.414.13-5.86%-6.48%114.67
Agios 1.9B2.891.3260.26%1,798.26%3.61

Financial data is updated regularly. All figures are in the company's reporting currency.